Multisociety sedation curriculum for gastrointestinal endoscopy

Gastrointestinal Endoscopy

Volumn 76, Issue 1, 2012, Pages

  Vargo, John J ^a   DeLegge, Mark H ^b   Feld, Andrew D ^c   Gerstenberger, Patrick D ^d   Kwo, Paul Y ^e   Lightdale, Jenifer R ^f   Nuccio, Susan ^g   Rex, Douglas K ^e   Schiller, Lawrence R ^h  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Digestive Health Associates   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g ST LUKE S MEDICAL CENTER   (United States)

^h BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; DIAZEPAM; DIPHENHYDRAMINE; DROPERIDOL; FENTANYL; FLUMAZENIL; KETAMINE; MIDAZOLAM; NALOXONE; NITROUS OXIDE; OPIATE; PETHIDINE; PROMETHAZINE; PROPOFOL; SEDATIVE AGENT;

AGITATION; ANALGESIA; ANESTHESIST; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL COMPETENCE; CLINICAL PROTOCOL; CONSCIOUS SEDATION; CURRICULUM; DEEP SEDATION; DIZZINESS; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL ENDOSCOPY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; INFORMED CONSENT; LACTATION; MEDICAL EDUCATION; PATIENT ASSESSMENT; PATIENT MONITORING; PHLEBITIS; PHYSICIAN; PREGNANT WOMAN; PRIORITY JOURNAL; QT PROLONGATION; RESPIRATION DEPRESSION; REVIEW; RISK MANAGEMENT; SEDATION; SIDE EFFECT; VOMITING; WITHDRAWAL SYNDROME;

EID: 84862684457     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2012.03.001     Document Type: Article

References (62)

1. Aho M, Erkola O, Kallio A, et al. Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole. J Clin Anesth 1993;5:194-203.
2. Alarcon FO, Baudet Arteaga JS, et al. Utility of routine use of reversion after sedation in outpatient colonoscopy. Gastroenterol Hepatol 2005;28:10-4.
3. Andrews PJ, Wright DJ, Lamont MC. Flumazenil in the outpatient. A study following midazolam as sedation for upper gastrointestinal endoscopy. Anaesthesia 1990;45:445-8.
4. Babenco HD, Blouin RT, Conard P, et al. Diphenhydramine increases ventilatory drive during alfentanil infusion. Anesthesiology 1998;89:642-7.
5. Bailey PL, Pace NL, Ashburn, et al. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990;73:826-30.
6. Bartelsman JF, Sars PR, Tytgat GN. Flumazenil used for reversal of midazolam-induced sedation in endoscopy outpatients. Gastrointest Endosc 1990;36(Suppl 3):S9-12.
7. Basu R, Dodge H, Stoehr GP, et al. Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. Am J Geriatr Psychiatry 2003;11:205-13.
8. Belleville JP, Ward D, Bloor BC, et al. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992;77:1125-33.
9. Blossom DB, Chen TH, Li J, et al. Self-limited febrile syndromes temporally associated with the use of propofol for sedation in gastrointestinal endoscopic procedures. Pharmacoepidemiol Drug Saf 2009;18:344-8.
10. Buck ML, Blumer JL. Opioids and other analgesics. Adverse effects in the intensive care unit. Crit Care Clin 1991;7:615-37.
11. Campbell RL, Ross GA, Campbell JR, et al. Comparison of oral chloral hydrate with intramuscular ketamine, meperidine, and promethazine for pediatric sedation-preliminary report. Anesth Prog 1998;45:46-50.
12. Chang AC, Solinger MA, Yang DT, et al. Impact of flumazenil on recovery after outpatient endoscopy: a placebo-controlled trial. Gastrointest Endosc 1999;49:573-9.
13. Classen DC, Pestotnik SL, Evans RS, et al. Intensive surveillance of midazolam use in hospitalized patients and the occurrence of cardiorespiratory arrest. Pharmacotherapy 1992;12:213-6.
14. Cohen JB, Haber GB, Dorai JA, et al. A randomized double blind study of the use of droperidol for conscious sedation during therapeutic endoscopy in difficult to sedate patients. Gastrointest Endosc 2000;51:546-51.
15. Cole SG, Brozinsky S, Isenberg JI. Midazolam, a new more potent benzodiazepine, compared with diazepam: a randomized, double-blind study of preendoscopic sedatives. Gastrointest Endosc 1983;29:219-22.
16. Cressman WA, Plostnieks J, Johnson PC. Absorption, metabolism and excretion of droperidol by human subjects following intramuscular and intravenous administration. Anesthesiology 1973;38:363-9.
17. Durrani Z, Winnie AP, Zsigmond EK, et al. Ketamine for intravenous regional anesthesia. Anesth Analg 1989;68:328-32.
18. Evans LT, Saberi S, Kim HM, et al. Pharyngeal anesthesia during sedated EGDs: is the "spray" beneficial? A meta-analysis and systematic review. Gastrointest Endosc 2006;63:761-6.
19. Fiset L, Milgrom P, Beirne OR, et al. Disinhibition of behaviors with midazolam: report of a case. J Oral Maxillofac Surg 1992;50:645-9.
20. Gan TJ. "Black box" warning on droperidol: report of the FDA convened expert panel. Anesth Analg 2004;98:1809.
21. Gibiansky E, Struys MM, Gibiansky L, et al. Aquavan injection, a water-soluble prodrug of propofol, as a bolus injection. A phase I dose-escalation comparison with diprivan (part 1). pharmacokinetics. Anesthesiology 2005;103:718-29.
22. Gilger MA, Spearman RS, Dietrich CL, et al. Safety and effectiveness of ketamine as a sedative agent for pediatric GI endoscopy. Gastrointest Endosc 2004;59:659-63.
23. Green SM, Li J. Ketamine in adults: what emergency physicians need to know about patient selection and emergence reactions. Acad Emerg Med 2000;7:278-81.
24. Greenblatt DJ, Abernethy DR. Midazolam pharmacology and pharmacokinetics. Anesth Rev 1985;12:17-20.
25. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705.
26. Hara M, Kai Y, Ikemoto Y. Propofol activates GABA A receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 1993;79:781-8.
27. Precedex (dexmedetomidine hydrochloride) injection for infusion (following dilution). FDA Medwatch safety information and adverse event reporting program. Available at: http://www.fda.gov/safety/medwatch/ safetyinformation/safetyalertsforhumanmedicalproducts/ucm172364.htm. Accessed November 12, 2011.
28. Jalowiecki P, Rudner R, Gonciarz M, et al. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology 2005;103:269-73.
29. Jasinski DR, Martin WR, Haertzen CA. The human pharmacology and abuse potential of Nallylnoroxymorphone (naloxone). J Pharmacol Exp Ther 1967;157:420-6.
30. Kankaria A, Lewis JH, Ginsberg G, et al. Flumazenil reversal of psychomotor impairment due to midazolam or diazepam for conscious sedation for upper endoscopy. Gastrointest Endosc 1996;44:416-21.
31. Kanto JH. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy 1985;5:138-55.
32. Kirberg A, Sagredo R, Montalva G, et al. Ketamine for pediatric endoscopic procedures and as a sedation complement for adult patients. Gastrointest Endosc 2005;61:501-2.
33. Lebrun HI. Neurleptanalgesia in upper alimentary endoscopy. Gut 1976;17:655-8.
34. Lee MG, Hanna W, Harding H. Sedation for upper gastrointestinal endoscopy: a comparative study of midazolam and diazepam. Gastrointest Endosc 1989;35:82-4.
35. Maslekar SK, Hughes M, Skinn E, et al. Randomised controlled trial of sedation for colonoscopy: entonox versus intravenous sedation. Gastrointest Endosc 2006;63:AB97.
36. Mather LE, Tucker GT, Pflug AE, et al. Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers. Clin Pharmacol Ther 1975;17:21-30.
37. Moore TJ, Walsh CS, Cohen MR. Reported adverse event cases of methemoglobinemia associated with benzocaine products. Arch Intern Med 2004;164:1192-6.
38. Morcos WE, Payne JP. The induction of anaesthesia with propofol (Diprivan) compared in normal and renal failure patients. Postgrad Med J 1985;61:62-3.
39. Mordel A, Winkler E, Almog S, et al. Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose. Crit Care Med 1992;20:1733-4.
40. Moser JD, Caldwell JB, Rhule FJ. No more than necessary: safety and efficacy of low-dose promethazine. Ann Pharmacother 2006;40:45-8.
41. Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med 1997;15:357-65.
42. Paspatis GA, Manolaraki M, Xirouchakis G, et al. Synergistic sedation with midazolam and propofol versus midazolam and pethidine in colonoscopies: a prospective, randomized study. Am J Gastroenterol 2002;97:1963-7.
43. Patel D, Chopra S, Berman MD. Serious systemic toxicity resulting from use of tetracaine for pharyngeal anesthesia in upper endoscopic procedures. Dig Dis Sci 1989;34:882-4.
44. Reimann FM, Samson U, Derad I, et al. Synergistic sedation with low-dose midazolam and propofol for colonoscopies. Endoscopy 2000;32:239-44.
45. Reves JG, Fragen RJ, Vinik HR, et al. Midazolam: pharmacology and uses. Anesthesiology 1985;62:310-24.
46. Reves JG, Glass PS, Lubarsky DA, et al. Intravenous nonopioid anesthetics. In: Miller RD, editor. Miller's anesthesia. Philadelphia (Pa): Elsevier Churchill Livingstone; 2005. p. 317-78.
47. Robb ND, Hargrave SA. Tolerance to intravenous midazolam as a result of oral benzodiazepine therapy: a potential problem for the provision of conscious sedation in dentistry. Anesth Pain Control Dent 1993;2:94-7.
48. Saunders BP, Fukumoto M, Halligan S, et al. Patientadministered nitrous oxide/oxygen inhalation provides effective sedation and analgesia for colonoscopy. Gastrointest Endosc 1994;40:418-21.
49. Stack CG, Rogers P, Linter SP. Monoamine oxidase inhibitors and anaesthesia. A review. Br J Anaesth 1988;60:222-7.
50. Stark RD, Binks SM, Dutka VN, et al. A review of the safety and tolerance of propofol (Diprivan). Postgrad Med J 1985;61(Suppl 3):152-6.
51. Struys MM, Vanluchene AL, Gibiansky E, et al. Aquavan injection, a water-soluble prodrug of propofol as a bolus injection: a phase I dose-escalation comparison with diprivan (part 2). Pharmacodynamics and safety. Anesthesiology 2005;103:730-43.
52. Szabadi E, Bradshaw CM, Freeman C, et al. The histaminergic system of the brain: its roles in arousal and autonomic regulation. Neuropsychopharmacol Hung 2004;6:163-4.
53. Thomas VL, Sutton DN, Saunders DA. The effect of fentanyl on propofol requirements for day case anaesthesia. Anaesthesia 1988;43:73-5.
54. Tu RH, Grewall P, Leung JW, et al. Diphenhydramine as an adjunct to sedation for colonoscopy: a doubleblind randomized, placebo-controlled study. Gastrointest Endosc 2006;63:87-94.
55. Watcha MF, White PF. New antiemetic drugs. Int Anesthesiol Clin 1995;33:1-20.
56. White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36.
57. White PF. Propofol pharmacokinetics and pharmacodynamics. Semin Anesth 1988;7:4-20.
58. Wilcox CM, Forsmark CE, Cello JP. Utility of droperidol for conscious sedation in gastrointestinal endoscopic procedures. Gastrointest Endosc 1990;36:112-5.
59. Wille RT, Chaffee BW, Ryan ML, et al. Pharmacoeconomic evaluation of flumazenil for routine outpatient EGD. Gastrointest Endosc 2000;51:282-7.
60. Willie RT, Barnett JL, Chey WD, et al. Routine droperidol premedication improves sedation for ERCP. Gastrointest Endosc 2000;52:362-6.
61. Yimchareon P, Fogel E, Kovacs R, et al. Droperidol, when used for sedation during ERCP, may prolong the QT interval. Gastrointest Endosc 2006;63:979-85.
62. Young D. FDA advisory panel discusses droperidol concerns. Am J Health Syst Pharm 2004;61:219-22.